GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai MicroPort MedBot (Group) Co Ltd (HKSE:02252) » Definitions » Selling and Marketing Expense

Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Selling and Marketing Expense : HK$222.8 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai MicroPort MedBot (Group) Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Shanghai MicroPort MedBot (Group) Co's Selling and Marketing Expense for the six months ended in Dec. 2024 was HK$123.5 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was HK$222.8 Mil.

Shanghai MicroPort MedBot (Group) Co Selling and Marketing Expense Historical Data

The historical data trend for Shanghai MicroPort MedBot (Group) Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai MicroPort MedBot (Group) Co Selling and Marketing Expense Chart

Shanghai MicroPort MedBot (Group) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling and Marketing Expense
Get a 7-Day Free Trial 3.19 96.96 205.52 260.79 222.01

Shanghai MicroPort MedBot (Group) Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 133.87 138.81 121.98 99.28 123.54

Shanghai MicroPort MedBot (Group) Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$222.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai MicroPort MedBot (Group) Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Shanghai MicroPort MedBot (Group) Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai MicroPort MedBot (Group) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai MicroPort MedBot (Group) Co Ltd (HKSE:02252) » Definitions » Selling and Marketing Expense
Comparable Companies
HKSE:00853 HKSE:02291 HKSE:01302 HKSE:01789 HKSE:01858 HKSE:02190 HKSE:02172 HKSE:01763 HKSE:09996 HKSE:09877 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
1601 Zhangdong Road, Room 101, Area B, Building 1, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Website
https://www.medbotsurgical.com
Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. Its business covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives key revenue from the People's Republic of China, followed by Europe, Africa, Australia, and other regions.
Executives
He Chao 2201 Interest of corporation controlled by you
Ji Shufang 2202 Interest of your spouse
Shang Hai Qing Zhen Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2103 Interests held jointly with another person
Wei Chuang Yi Liao Ke Xue You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Qing Min Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2101 Beneficial owner
Wei Chuang Tou Zi Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Yuan Shuai 2201 Interest of corporation controlled by you
Wu Kaili 2202 Interest of your spouse
Shenzhen Gao Ling Tiancheng Phase Iii Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shenzhen Gao Ling Muqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Xiamen Gao Ling Ruiqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Zhuhai Gao Ling Chongheng Equity Investment Llp 2101 Beneficial owner
Shang Hai Wei Chuang Tou Zi Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Mo Hua Ren Gong Zhi Neng Ke Ji You Xian Gong Si 2103 Interests held jointly with another person

Shanghai MicroPort MedBot (Group) Co Headlines

No Headlines